Bayer AG Third Quarter 2018 Results and News Conference Call

Bayer: Good performance in a challenging environment, Group outlook confirmed

Group sales increase by 1.9 percent (Fx & portfolio adj.) to 9.905 billion euros / EBITDA before special items level year on year at 2.202 billion euros ...

Access to Seeds Index ranks Bayer 2nd on efforts to support smallholder farmers in Asia

Global survey highlights patients’ needs in connection with diagnostic procedures

Survey shows 60% of patients felt more information would have been beneficial prior to their imaging procedure ...

Eighth anniversary of Bayer Young Science Ambassadors tour

Project starts into its eighth year / Ambassadors have reached more than 33 thousand pupils up to now ...

Phase III trial of darolutamide in patients with non-metastatic castration-resistant prostate cancer meets primary endpoint

The safety and tolerability observed in the trial were consistent with previously published data on darolutamide ...

Expanded larotrectinib data confirm findings on efficacy and safety in adult and pediatric patients with TRK fusion cancer across various tumor types

Data presented across 122 adult and pediatric patients (55 patients from primary dataset plus supplementary dataset with 67 additional patients) with TRK fusion cancer across various tumor types ...

Immediate support for earthquake victims in Indonesia

Company makes EUR 115,000 available in immediate assistance for people impacted in Central Sulawesi province ...

Bayer’s biological crop protection product combats bacterial and fungal crop diseases

Young agricultural enthusiasts head to Rome for the UN Committee on Food Security

On World Food Day, eight Youth Ag Summit alumni arrive in Rome, Italy for the 45th UN CFS ...